DJIA 18,030.21 6.04 0.03%
NASDAQ 4,773.47 0.00 0.00%
S&P 500 2,081.88 -0.29 -0.01%
market minute promo

Cubist Pharmaceuticals (NASDAQ: CBST)



company name or ticker
Company Photos
(Click to zoom)

Today's Market: Mergers And Acquisitions, Content Deals And Analyst Moves

Is It Time to Buy This Growth Stock?

Specialty and generic drugmaker Actavis has been going through a rapid growth spurt, spurred by its numerous acquisitions. After completing a mega merger with Botox-maker Allergan, can the uptrend continue?

Merck, Cubist Agree to $9.5 Billion Acquisition

Why Cubist Pharmaceuticals Inc. Shares Soared in After-Hours Trading on Friday

Antibiotic drug developer Cubist Pharmaceuticals surges in after-hours trading following a report that a large pharmaceutical company may be interested in acquiring it for a handsome premium.

Benzinga's Weekend M&A Chatter

Merck in Talks to Acquire Cubist for More Than $7B - Reports

Merck in Talks to Acquire Cubist for ~$100/Share

Corporate Deal Executives Bring More To the Table Than Cash

The Most Important FDA Decision We're Watching This Month

Three Motley Fool analysts tell investors which three FDA decisions they'll be watching closely in December.

5 Critical Biotech Drug Dates and Events for December

See More Articles...